IL17A and inflammatory bowel disease: In active IBD, tissue-resident T cells fulfill a multitude of different functions: pro-inflammatory—through cytotoxic (TNF, IFNG) or antimicrobial (IL22, IL17A) pathways, and anti-inflammatory—through suppressive pathways (IL10, TIGIT).